What is she best known for?
The fields of study she is best known for:
Her primary scientific interests are in Molecular biology, Antibody, Antigen, Immune system and Virology.
Her study in Molecular biology is interdisciplinary in nature, drawing from both Peptide sequence, COS cells, B cell and Binding site.
Her research combines Blot and Antibody.
She has included themes like Cancer cell, Cancer, Cancer research and Fusion protein in her Immune system study.
Her work carried out in the field of Virology brings together such families of science as Epitope, Plasmodium and Hepatocyte.
She focuses mostly in the field of Glycoprotein, narrowing it down to topics relating to CD81 and, in certain cases, Transmembrane protein, Tetraspanin, Infectivity, Vacuole and Plasmodium yoelii.
Her most cited work include:
- The tetraspanin superfamily: molecular facilitators. (833 citations)
- The tetraspanin web modulates immune-signalling complexes. (475 citations)
- CD81 (TAPA-1): A MOLECULE INVOLVED IN SIGNAL TRANSDUCTION AND CELL ADHESION IN THE IMMUNE SYSTEM (455 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Molecular biology, Antibody, Immunology, Cell biology and CD81.
Shoshana Levy has researched Molecular biology in several fields, including B cell, Biochemistry, Gene and Antigen.
Her Antibody research is multidisciplinary, incorporating perspectives in B-cell lymphoma and Virology.
Her research investigates the connection with Immunology and areas like Cytotoxic T cell which intersect with concerns in T cell.
Her Cell biology research incorporates elements of Tetraspanin and Cell growth.
Her work investigates the relationship between CD81 and topics such as Glycoprotein that intersect with problems in Binding site.
She most often published in these fields:
- Molecular biology (43.87%)
- Antibody (29.03%)
- Immunology (22.58%)
What were the highlights of her more recent work (between 2013-2019)?
- CD81 (21.29%)
- Tetraspanin (16.77%)
- Cancer research (9.68%)
In recent papers she was focusing on the following fields of study:
Shoshana Levy mainly focuses on CD81, Tetraspanin, Cancer research, Immunology and Metastasis.
She combines subjects such as Molecular biology and Antibody, Monoclonal antibody, B cell with her study of CD81.
Her Molecular biology study integrates concerns from other disciplines, such as Budding, Reverse transcriptase, SAMHD1, Immunoglobulin light chain and Viral replication.
Her Tetraspanin study which covers Cell biology that intersects with CD19.
Her work in Immunology addresses subjects such as Cytotoxic T cell, which are connected to disciplines such as Pathogen, Immunity and Microbiology.
Within one scientific family, Shoshana Levy focuses on topics pertaining to Immune system under Metastasis, and may sometimes address concerns connected to Cancer cell.
Between 2013 and 2019, her most popular works were:
- Eradication of spontaneous malignancy by local immunotherapy (183 citations)
- CD81 and hepatitis C virus (HCV) infection. (59 citations)
- Function of the tetraspanin molecule CD81 in B and T cells (50 citations)
In her most recent research, the most cited papers focused on:
Shoshana Levy focuses on Tetraspanin, CD81, Cancer research, Immune system and Immunology.
In her study, Mutation, B cell, Signal transduction, CD19 and Cell biology is inextricably linked to Acquired immune system, which falls within the broad field of Tetraspanin.
Her CD81 research incorporates themes from Budding, Reverse transcriptase, SAMHD1, Molecular biology and Viral replication.
Her Immunology study frequently draws connections between adjacent fields such as Virology.
Her study looks at the relationship between Immunotherapy and fields such as Cancer cell, as well as how they intersect with chemical problems.
Her Antibody study combines topics from a wide range of disciplines, such as Virus, Hepacivirus and Lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
